Publication:
Consumption of pomegranate decreases plasma lipopolysaccharide-binding protein levels, a marker of metabolic endotoxemia, in patients with newly diagnosed colorectal cancer: a randomized controlled clinical trial

Loading...
Thumbnail Image
Date
2018-05
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
González Sarrías, A. ; Núñez Sánchez, María Angeles ; Ávila Gálvez, M. A. ; Monedero Saiz, T. ; Rodríguez Gil, F. J. ; Martínez Díaz, Francisco ; Selma, Victoria ; Espín, Juan Carlos
item.page.secondaryauthor
item.page.director
Publisher
Royal Society of Chemistry
publication.page.editor
DOI
https://doi.org/10.1039/c8fo00264a
item.page.type
info:eu-repo/semantics/article
Description
© The Royal Society of Chemistry 2018. This document is the Published version of a Published Work that appeared in final form in Food and Function. To access the final edited and published work see https://doi.org/ 10.1039/c8fo00264a
Abstract
Gut microbiota dysbiosis alters the intestinal barrier function, increases plasma lipopolysaccharide (LPS) levels, which promotes endotoxemia, and contributes to the onset and development of colorectal cancer (CRC). We report here for the first time the reduction of plasma LPS-binding protein (LBP) levels, a marker of endotoxemia, after pomegranate consumption in newly diagnosed CRCpatients.
publication.page.subject
Citation
Food Funct., 2018, 9, 2617–2622
item.page.embargo
Collections